pXCX.CMV.ACREB.WPRE
(Plasmid
#38051)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 38051 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepXCXCMV
- Total vector size (bp) 10080
-
Modifications to backboneco-expresses EGFP using an IRES
-
Vector typeMammalian Expression, Adenoviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameA-CREB
-
Alt nameACREB
-
Alt namea dominant-negative inhibitor of CREB
- Promoter CMV
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site unknown (unknown if destroyed)
- 3′ cloning site unknown (unknown if destroyed)
- 5′ sequencing primer CMV-F (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Adenoviral plasmid for overexpression of A-CREB from CMV promoter with WPRE
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pXCX.CMV.ACREB.WPRE was a gift from James Uney (Addgene plasmid # 38051 ; http://n2t.net/addgene:38051 ; RRID:Addgene_38051) -
For your References section:
Adenoviral expression of CREB protects neurons from apoptotic and excitotoxic stress. Glover CP, Heywood DJ, Bienemann AS, Deuschle U, Kew JN, Uney JB. Neuroreport. 2004 May 19;15(7):1171-5. 10.1097/00001756-200405190-00018 PubMed 15129168